# Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia

> **NCT00326287** · PHASE3 · COMPLETED · sponsor: **Basilea Pharmaceutica** · enrollment: 638 (actual)

## Conditions studied

- Pneumonia

## Interventions

- **DRUG:** Ceftobiprole medocaril
- **DRUG:** Ceftriaxone with or without Linezolid

## Key facts

- **NCT ID:** NCT00326287
- **Lead sponsor:** Basilea Pharmaceutica
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 638 (ACTUAL)
- **Last updated:** 2012-08-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00326287

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00326287, "Ceftobiprole in the Treatment of Patients With Community-Acquired Pneumonia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00326287. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*